Analytical Development Services

Keeping you on-point, on-track, and on-spec

A High-Performance Partner to Help Execute Your Product Process Development

Emergent Bioservices offers the technical capability, experienced personnel, equipment resources, and demonstrated expertise to support the development and understanding of your product with a full range of characterization methodologies and assay development.

  • Technology transfer
  • Method development
  • Optimization, feasibility, and robustness studies
  • Development of bio-immuno and complex potency assays
  • Method qualification and validation
  • Early phase release & stability testing
  • Drug substance and drug product characterization testing
  • Validation and characterization testing to support IND and BLA/ANDA submissions
  • Regular investments in the latest process development technologies and equipment

With more than 20 years of process development experience, Emergent Bioservices provides its clients with distinct advantages for their biological programs:

  • Monoclonal Antibodies
  • Antibody Fragments
  • Fusion Proteins
  • Enzymes
  • Recombinant Proteins
  • Nanoparticle Platforms (mRNA-LNP, protein nanoparticles)
  • Viral Platforms (Adeno, MVA, rVSV, VLP)
  • Peptides

Technologies and Capabilities to Advance Your Program to the Next Level


Chemical Capabilities Biochemical Capabilities Stability Testing Conditions
  • LC-MS
  • Peptide mapping
  • Oligosaccharide profiling
  • Amino acid analysis
  • FTIR
  • JESS
  • ELISA (titer and impurity)
  • Western blotting
  • Total Protein
  • Compendial testing
  • Agarose Gel Electrophoresis
  • PCR, qPCR, and RT-qPCR
  • Potency assays
  • Viral infectivity
  • Routine cell culture capabilities
  • UV-Vis and Fluorescence Spectrophotometry
  • BLI
  • -65 °C and below
  • -40 °C
  • -20 °C
  • -5 °C
  • -25 ˚C
  • -40 ˚C

Let’s Start A Conversation

Connect now